- Home
- WIMI vs ASRT Comparison
WIMI vs ASRT Comparison
Compare WIMI & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WIMI | ASRT |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 75.1M |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | WIMI | ASRT |
|---|---|---|
| Price | $2.84 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 68.4K | ★ 343.3K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | $61,329,146.00 | ★ $137,354,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.99 | ★ N/A |
| Revenue Growth | N/A | ★ 9.22 |
| 52 Week Low | $2.24 | $0.51 |
| 52 Week High | $9.66 | $1.01 |
Technical Indicators
Market Signals| Indicator | WIMI | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 41.85 |
| Support Level | $2.77 | $0.75 |
| Resistance Level | $3.26 | $0.80 |
| Average True Range (ATR) | 0.17 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 28.55 | 29.52 |
Price Performance
Historical ComparisonAbout WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.